KLK3 and metastatic prostate carcinoma: Currently, 27 men are on PSA surveillance, 22 on androgen deprivation therapy (ADT), 10 are having chemotherapy (2 with hormone-sensitive disease, 8 with castrate-resistant metastatic prostate cancer), 4 undergoing radiotherapy, 2 on watchful waiting, 2 having best supportive care (due to metastatic tumours of non-prostatic origin) and 1 being considered for salvage surgery.